Mobility Training to Improve Motor Behavior in Toddlers With or at Risk for Cerebral Palsy: A Pilot Study - Full Text View

Purpose

Background:

- People who have cerebral palsy often have difficulty walking and moving their legs. Cerebral palsy is sometimes not identified until a child is almost 2 years of age, which means that early motor skill development can be affected and can have repercussions for later development. Studies in adults with neurological injuries (e.g., stroke, spinal cord injury) have shown that it is important to start intensive therapy soon after the injury, and it may be true that starting intensive therapy at a young age will be helpful for children with cerebral palsy. Researchers are interested in testing the effectiveness of a special body weight support system for mobility training in young children who have or are at risk for cerebral palsy.

Objectives:

- To study the effectiveness of a mobility training program on the motor skills of young children who have or are at risk for cerebral palsy.

Eligibility:

- Children between 12 and 36 months of age who have delayed motor skills and either have been diagnosed with cerebral palsy or show evidence of spasticity or brain damage.

Design:

This study involves two 6-week study phases: a baseline phase and a mobility training program.
Participants will be screened with a physical examination and medical history.
During the baseline phase, participants will have mobility testing sessions once every 2 weeks. These tests will measure motor development and ability, including ease and speed of walking.
Participants' parents/guardians will receive a mobility sensor for the child to wear at home for at least 6 hours (awake time) to measure activity and mobility levels outside of the testing sessions.
After 6 weeks of baseline testing, participants will have 6 weeks of mobility training for 30 minutes 3 days per week. Training will involve motor tasks with weight support, conducted by a pediatric physical therapist. Activities may include walking, climbing inclines or steps, or squatting to reach toys. All sessions will be videotaped.
To evaluate the effects of the therapy program, participants will have testing sessions every 2 weeks.
Parents/guardians will also complete questionnaires to provide feedback on the effectiveness of the therapy program.

Condition	Intervention	Phase
Developmental Delay Cerebral Palsy	Behavioral: mobility training with dynamic body weight support	Phase 1


Study Type:	Interventional
Study Design:	Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: No masking Primary Purpose: Treatment
Official Title:	Mobility Training to Improve Motor Behavior in Toddlers With or at Risk for Cerebral Palsy - A Pilot Study

Resource links provided by NLM:

MedlinePlus related topics: Cerebral Palsy Paralysis

Genetic and Rare Diseases Information Center resources: Cerebral Palsy

U.S. FDA Resources

Further study details as provided by National Institutes of Health Clinical Center (CC):

Primary Outcome Measures:

Change in motor delay

Secondary Outcome Measures:

Completion rate, change in gross motor function, change in functional mobility, change in walking speed, change in physical activity


Enrollment:	5
Study Start Date:	November 15, 2010
Study Completion Date:	June 6, 2014
Primary Completion Date:	June 6, 2014 (Final data collection date for primary outcome measure)

Detailed Description:

The purpose of this pilot study is to test the feasibility and effects of a functional mobility training program on the motor ability and physical activity of young children who are developmentally delayed and at risk for cerebral palsy (CP). The study includes a sample of 10 participants between 12-36 months of age who have at least a 4 month motor delay and are at risk for CP in a single-subject research design with repeated measures during baseline and intervention phases. Participants will have biweekly assessments during the 6 week baseline phase and the subsequent 6 week mobility training phase, followed by a final assessment after 6 weeks of treatment withdraw. Assessments and training will occur in the Functional and Applied Biomechanics (FAB) section. The mobility training program consists of three days per week of 30 minute treatment sessions using dynamic body weight support during a variety of functional motor tasks. Children will be assisted, but not limited, by the dynamic weight support system while they are encouraged to participate in a variety of age-appropriate mobility tasks. It is hypothesized that this system combined with the functional activity practice will facilitate the development of postural control and strength, and thereby improve walking ability. The primary outcome measures are completion rate and gross motor ability as measured by the Gross Motor Function Measure (GMFM). Secondary outcome measures include the amount of gross motor delay as measured by the Bayley Motor Scale (BMS),, the Functional Mobility Scale (FMS), spatiotemporal gait measures, and amount of physical activity in daily life. Results of this pilot study will be used to refine the mobility training program, evaluate the appropriateness of the selected outcome measures, and to provide preliminary data for a larger scale clinical trial.

Eligibility


Ages Eligible for Study:	12 Months to 36 Months (Child)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

INCLUSION CRITERIA:
1. 12-36 months of age
2. greater than or equal to 4 months of gross motor delay corrected for gestational age (measured by Bayley Motor Scale)
3. Diagnosis of bilateral spastic cerebral palsy OR neurological evidence of spasticity or brain damage
4. Ability to pull to stand at a surface without assistance
5. Cognitive ability to follow one-step commands
6. Availability to return to NIH CC with parent or caregiver for required treatment and assessment sessions

EXCLUSION CRITERIA:

Unilateral cerebral palsy
Secondary orthopedic, neuromuscular or cardiovascular condition unrelated to CP
Greater than six months of independent walking experience
History of surgery or injury to the lower extremities in the past 6 months

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01253083

Locations


United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892

Sponsors and Collaborators

National Institutes of Health Clinical Center (CC)

Investigators


Principal Investigator:	Diane L Damiano, Ph.D.	National Institutes of Health Clinical Center (CC)

More Information

Publications:

Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, Dan B, Jacobsson B. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007 Feb;109:8-14. Erratum in: Dev Med Child Neurol. 2007 Jun;49(6):480.

Yeargin-Allsopp M, Van Naarden Braun K, Doernberg NS, Benedict RE, Kirby RS, Durkin MS. Prevalence of cerebral palsy in 8-year-old children in three areas of the United States in 2002: a multisite collaboration. Pediatrics. 2008 Mar;121(3):547-54. doi: 10.1542/peds.2007-1270.

Odding E, Roebroeck ME, Stam HJ. The epidemiology of cerebral palsy: incidence, impairments and risk factors. Disabil Rehabil. 2006 Feb 28;28(4):183-91. Review.


Responsible Party:	National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:	NCT01253083 History of Changes
Other Study ID Numbers:	110037 11-CC-0037
Study First Received:	December 2, 2010
Last Updated:	May 12, 2017

Keywords provided by National Institutes of Health Clinical Center (CC):


Mobility Developmental Delay Cerebral Palsy Early Walking Postural Control

Additional relevant MeSH terms:


Paralysis Cerebral Palsy Neurologic Manifestations Nervous System Diseases	Signs and Symptoms Brain Damage, Chronic Brain Diseases Central Nervous System Diseases

ClinicalTrials.gov processed this record on June 23, 2017